MOBKL1B Activators would refer to a group of chemical compounds that specifically target and increase the activity of the MOB kinase activator 1B (MOBKL1B) protein. MOBKL1B is part of the MOB family of proteins, which are known to interact with kinases and play crucial roles in cell cycle regulation and cellular proliferation. The activators of MOBKL1B would be designed to bind to this protein and enhance its interaction with its kinase partners, thereby amplifying its natural cellular functions. Such compounds could act by stabilizing the protein, increasing its affinity for kinases, or upregulating its expression levels within cells. They would not be intended to elicit a direct response but rather to modulate the intrinsic activity of MOBKL1B, thus influencing the pathways in which it is involved.
To successfully develop MOBKL1B Activators, an extensive understanding of the protein's structure and function would be required. This would involve in-depth research into the gene encoding MOBKL1B, analysis of its regulatory elements, and exploration of its expression patterns across various cell types. Structural biologists would aim to elucidate the protein's three-dimensional arrangement, particularly focusing on the domains responsible for kinase interaction, using techniques such as cryo-electron microscopy or NMR spectroscopy. This structural knowledge would be pivotal in identifying potential active sites where activator molecules could bind. Concurrently, biochemical assays would need to be established to monitor the activity of MOBKL1B in the presence of these potential activators, helping to clarify how the interaction between MOBKL1B and its kinase partners modulates cellular processes. With this information, high-throughput chemical screening could be utilized to identify lead compounds that demonstrate an activating effect on MOBKL1B. These lead compounds would then undergo a process of chemical optimization to enhance their potency, specificity, and cellular permeability, resulting in the development of a diverse array of MOBKL1B Activators, each with a unique chemical signature designed to modulate the protein's activity within the cell.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
AICAR mimics cellular energy depletion and can activate AMPK, potentially influencing the Hippo pathway and MOBKL1B expression. | ||||||
Simvastatin | 79902-63-9 | sc-200829 sc-200829A sc-200829B sc-200829C | 50 mg 250 mg 1 g 5 g | $31.00 $89.00 $135.00 $443.00 | 13 | |
Statins inhibit HMG-CoA reductase, affecting cellular processes and potentially signaling through the Hippo pathway to regulate MOBKL1B expression. | ||||||
1,1-Dimethylbiguanide, Hydrochloride | 1115-70-4 | sc-202000F sc-202000A sc-202000B sc-202000C sc-202000D sc-202000E sc-202000 | 10 mg 5 g 10 g 50 g 100 g 250 g 1 g | $20.00 $43.00 $63.00 $156.00 $260.00 $510.00 $31.00 | 37 | |
Metformin activates AMPK, which might influence the Hippo pathway and subsequently affect MOBKL1B expression. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitors affect downstream signaling pathways including the Hippo pathway, potentially altering MOBKL1B expression. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, a key nutrient sensor, potentially impacting the Hippo pathway and MOBKL1B expression as a cellular response. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Glucocorticoids affect various signaling pathways and might indirectly influence MOBKL1B expression through stress response pathways. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium influences the GSK-3β pathway, which may intersect with Hippo signaling, thereby potentially affecting MOBKL1B expression. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid influences cell differentiation and proliferation, possibly impacting MOBKL1B expression as part of the signaling response. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $176.00 $426.00 | 43 | |
Doxorubicin induces DNA damage response and could influence various signaling pathways, including those regulating MOBKL1B expression. | ||||||
Sodium Salicylate | 54-21-7 | sc-3520 sc-3520A sc-3520B sc-3520C | 1 g 25 g 500 g 1 kg | $10.00 $26.00 $82.00 $139.00 | 8 | |
Sodium salicylate can inhibit NF-κB signaling and might also impact signaling pathways related to the regulation of MOBKL1B expression. | ||||||